Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.

Favourable effects were noted in this preliminary study with the non-pathogenic helminth, Trichuris suis which has already proved effective in  inflammatory bowel disease

Risk factorsMultiple sclerosis
Enhanced by Zemanta

No comments: